Device Trial Radar · NCT05559567
Axial Length With Adult Onset Myopia (ALWAOM)
Last checked: Nov 20, 2026Latest source record: Aug 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
100
Planned (sponsor's estimate)
Start
Sep 1, 2023
Primary completion
May 2025
Study completion Aug 2025
Sponsor
- Lead sponsor
- Art Optical Contact Lens, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- University of Missouri, St. Louis
- First posted
- Sep 29, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 35 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Purpose: To determine axial length progression and its relationship with myopia onset and progression in adults.
Conditions
- Myopia
Interventions
OrthokeratologyDevice
The use of a specialty GP contact lens to temporarily correct myopia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Axial Length progressionTime frame: Two years
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Missouri-St. Louis College of Optometry
St Louis, Missouri
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.